AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVION LTD

0.039

+0.0025.41%

Volume:167.60K

Turnover:6K

Market Cap:4.26M

PE:-0.30

High:0.039

Open:0.037

Low:0.036

Close:0.037

52wk High:0.140

52wk Low:0.032

Shares:109.20M

Float Shares:56.74M

Volume Ratio:1.45

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.132

EPS(LYR):-0.122

ROE:-111.51%

ROA:-59.36%

PB:0.75

PE(LYR):-0.32

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+0.64%

China Concept Stocks+6.66%

Capital Flow

Inflow:

Outflow:

News

Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board

THOMSON REUTERS

Invion Ltd-Global Pdt Leader DR Colin Hopper Appointed Clinical Advisor

THOMSON REUTERS

Invion Ltd-Change of Directors' Interest Notices X 3

THOMSON REUTERS

BUZZ-Australia's Invion enters ophthalmology agreement with Sangmyung Innovation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/IVX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.039,"timestamp":1787551920000,"preClose":0.037,"halted":0,"volume":167604,"delay":0,"changeRate":0.054054054054054106,"nameEN":"INVION LTD","floatShares":56741426,"shares":109200637,"eps":-0.1322,"marketStatus":"Not Yet Opened","change":0.002,"latestTime":"08-24 16:12:00 AEST","open":0.037,"high":0.039,"low":0.036,"amount":6263,"amplitude":0.081081,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.1322,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.037,"openAndCloseTimeList":[[1787529600000,1787551200000]],"volumeRatio":1.4546988443801347,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IVX.AU","preClose":0.037,"auctionPrice":0.037,"auctionVolume":109410,"auction":3,"marketStatus":"盘后竞价","timestamp":1787551200777}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":56741426,"roa":"-59.36%","roe":"-111.51%","lyrEps":-0.122249,"volumeRatio":1.4546988443801347,"shares":109200637,"dividePrice":0,"high":0.039,"amplitude":0.081081,"preClose":0.037,"low":0.036,"week52Low":0.032,"pbRate":"0.75","psRate":"-3987.66","week52High":0.14,"institutionHeld":0,"latestPrice":0.039,"eps":-0.1322,"divideRate":0,"volume":167604,"delay":0,"ttmEps":-0.1322,"open":0.037,"prevYearClose":0.093,"prevWeekClose":0.037,"prevMonthClose":0.04,"prevQuarterClose":0.035,"fiveDayClose":0.038,"twentyDayClose":0.046,"sixtyDayClose":0.044},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660490054","title":"Invion Ltd-Ivx Credentialed International Biotech Leader Joins Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490054?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:22","pubTimestamp":1787095324,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUE3N4Y4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","IVX.AU","BK7509","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645011534","title":"Invion Ltd-Global Pdt Leader DR Colin Hopper Appointed Clinical Advisor","url":"https://stock-news.laohu8.com/highlight/detail?id=2645011534","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645011534?lang=en_us&edition=fundamental","pubTime":"2026-06-22 07:24","pubTimestamp":1782084281,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260621:nTUE4GFC1R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","IVX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644037965","title":"Invion Ltd-Change of Directors' Interest Notices X 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2644037965","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644037965?lang=en_us&edition=fundamental","pubTime":"2026-06-19 08:48","pubTimestamp":1781830106,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260619:nTUE9CXSQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","IVX.AU","BK7509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636884922","title":"BUZZ-Australia's Invion enters ophthalmology agreement with Sangmyung Innovation","url":"https://stock-news.laohu8.com/highlight/detail?id=2636884922","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636884922?lang=en_us&edition=fundamental","pubTime":"2026-05-19 12:53","pubTimestamp":1779166405,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Invion enters ophthalmology agreement with Sangmyung Innovation** Shares of Invion IVX.AX rise as much as 41.2% to A$0.072, their highest level since March 31** Life science co enters partnership with SANGMYUNG Innovation , a South Korean therapeutic solutions company for eye-related diseases** SANGMYUNG will fund and evaluate the Photosoft platform technology, Invion's photodynamic therapy , for the treatment of retinal vascular diseases** About 3.3 million shares change hands, 23.4x 30-day average ** Stock down 43% this year, including the day's move  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260519:nL4N41W0DL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVX.AU","BK7509","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/IVX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.006433},{"market":"AU","name":"China Concept Stocks","id":"package_au_concept_zgg","bkCode":"BK7509","changeRate":0.066559}]}}